JAC Advance Access originally published online on January 24, 2007
Journal of Antimicrobial Chemotherapy 2007 59(3):574-576; doi:10.1093/jac/dkl541
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Plasmid-mediated carbapenem-hydrolysing ß-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China
2nd Affiliated Hospital of Zhejiang University, Zhejiang University, 88 JieFang Rd, Hangzhou, China 310009
* Corresponding author. Tel: 00-86-571-8778-4633; Fax: 00-86-571-8781-4695; E-mail: chengong218@163.com
Keywords: antibiotic resistance , imipenem , Enterobacteriaceae
| The first 10% of the full text of this article appears below. |
Sir,
Carbapenems are considered to be one of the few drugs that are useful for the treatment of infections caused by multidrug-resistant isolates with high levels of AmpC or extended-spectrum ß-lactamase (ESBL) production. While carbapenem resistance has become a serious problem for non-fermenting bacteria, it has remained uncommon in Enterobacteriaceae. However, identification of carbapenem-resistant Enterobacteriaceae is increasingly common. Especially, reports of nosocomial infection due to carbapenem-resistant Serratia spp. have become significantly
Transparency declarations
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Shen, Z. Wei, Y. Jiang, X. Du, S. Ji, Y. Yu, and L. Li Novel Genetic Environment of the Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 among Enterobacteriaceae in China Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4333 - 4338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. D. Wang, J. C. Cai, H. W. Zhou, R. Zhang, and G.-X. Chen Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated {beta}-lactamase production and OmpK36 porin deficiency J. Med. Microbiol., September 1, 2009; 58(9): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Gootz, M. K. Lescoe, F. Dib-Hajj, B. A. Dougherty, W. He, P. Della-Latta, and R. C. Huard Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1998 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Petrella, N. Ziental-Gelus, C. Mayer, M. Renard, V. Jarlier, and W. Sougakoff Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A {beta}-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3725 - 3736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tibbetts, J. G. Frye, J. Marschall, D. Warren, and W. Dunne Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC {beta}-Lactamase in P. mirabilis J. Clin. Microbiol., September 1, 2008; 46(9): 3080 - 3083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Cai, H. W. Zhou, R. Zhang, and G.-X. Chen Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2014 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Naas, G. Cuzon, M.-V. Villegas, M.-F. Lartigue, J. P. Quinn, and P. Nordmann Genetic Structures at the Origin of Acquisition of the {beta}-Lactamase blaKPC Gene Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1257 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhang, L. Yang, J. C. Cai, H. W. Zhou, and G.-X. Chen High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression J. Med. Microbiol., March 1, 2008; 57(3): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Mendes, J. M. Bell, J. D. Turnidge, Q. Yang, Y. Yu, Z. Sun, and R. N. Jones Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene Antimicrob. Agents Chemother., February 1, 2008; 52(2): 798 - 799. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Walther-Rasmussen and N. Hoiby Class A carbapenemases J. Antimicrob. Chemother., September 1, 2007; 60(3): 470 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Leavitt, S. Navon-Venezia, I. Chmelnitsky, M. J. Schwaber, and Y. Carmeli Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital Antimicrob. Agents Chemother., August 1, 2007; 51(8): 3026 - 3029. [Abstract] [Full Text] [PDF]
|
|